ANAPTYSBIO, INC (ANAB) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $1.5 billion, ANAPTYSBIO, INC is a small-cap company. The stock currently trades at $53.99, down 1.68% today, with a 52-week range of $13.99–$57.74.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-5.12 | $-5.12 | +15.8% | |
| 2023 | $-6.08 | $-6.08 | -33.0% | |
| 2022 | $-4.57 | $-4.57 | -116.6% | |
| 2021 | $-2.11 | $-2.11 | — | |
| 2020 | — | — | — | |
| 2019 | $-0.75 | $-0.75 | -17.2% | |
| 2018 | $-0.64 | $-0.64 | -113.3% | |
| 2017 | $-0.30 | $-0.30 | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2024-12-31 | 2025-02-27 | 0001370053-25-000024 | SEC ↗ |
| 2023-12-31 | 2024-03-11 | 0001370053-24-000011 | SEC ↗ |
| 2022-12-31 | 2023-03-01 | 0001370053-23-000020 | SEC ↗ |
| 2021-12-31 | 2022-03-07 | 0001370053-22-000009 | SEC ↗ |
| 2020-12-31 | 2021-02-25 | 0001370053-21-000019 | SEC ↗ |
| 2019-12-31 | 2020-03-02 | 0001370053-20-000009 | SEC ↗ |
| 2018-12-31 | 2019-02-28 | 0001370053-19-000006 | SEC ↗ |
| 2017-12-31 | 2018-03-05 | 0001370053-18-000014 | SEC ↗ |
| 2016-12-31 | 2017-03-08 | 0001564590-17-003710 | SEC ↗ |